Applied DNA Ships LinearDNA™ to Another Development Customer
March 26th, 2020
Tag: LinearDNA
Provisional Patent Application Filed for High Sensitivity COVID-19 Diagnostic Assay
March 24th, 2020
APDN Secures Top-20 Pharmaceutical Manufacturer as Drug Development Customer
March 20th, 2020
Applied DNA Leverages COVID-19 Vaccine Development and Proprietary Linear DNA Manufacturing Capability to Design a High Sensitivity Diagnostic Kit for Virus Detection
March 19th, 2020
Applied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-Clinical Models
March 18th, 2020
Stony Brook firm working on coronavirus vaccine
March 3rd, 2020
APDN, Takis Biotech design four Covid-19 vaccine candidates
March 3rd, 2020
Applied DNA Speeds Coronavirus Vaccines Toward Tests
March 2nd, 2020
Applied DNA Sciences (NASDAQ: APDN) Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed
March 2nd, 2020